Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Albumin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global albumin market reached a value of US$ 5.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2027, exhibiting a CAGR of 6.15% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Albumin is a water-soluble globular protein present in blood plasma. It is synthesized in the liver and is essential for maintaining the blood volume and transportation of enzyme, hormone and bile salt molecules. It is commonly available in human, bovine and recombinant variants. They are crucial for sustaining the intravascular colloid osmotic pressure (COP) and preventing leakage of fluids into the tissue. It is commonly used as a blood volumizer for the treatment of rare diseases, burns, liver disorders, blood loss trauma and surgical complications. It is also utilized in pharmaceutical drugs for stabilization, enhancing surface absorption and reducing aggregation and oxidation. As a result, albumin finds extensive application in the manufacturing of drug delivery systems, therapeutics, culture media and vaccines.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Albumin Market Trends:

The increasing prevalence of chronic medical ailments across the globe is one of the key factors driving the growth of the market. Albumin is widely used in the treatment of hypovolemia, acute respiratory distress syndrome, nephrosis, renal dialysis, liver failure, cardiopulmonary disorders and hypoalbuminemia. Moreover, the rising geriatric population, which is more susceptible to such ailments is providing a thrust to the market growth. Additionally, the widespread adoption of human serum albumin (HSA) for replenishing proteins in human plasma and maintaining plasma colloid oncotic pressure is acting as another growth-inducing factor. It also aids in preventing the denaturation of active protein ingredients, thereby making it highly beneficial for the production of vaccines. Other factors, including the introduction of albumin-based nanoparticles, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market toward growth. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global albumin market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.

Breakup by Product:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin
     

Breakup by Application:

  • Therapeutics
  • Drug Formulation and Vaccine
  • Component of Media
  • Others
     

Breakup by End User:

  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Albumedix Ltd, Biotest AG, Celgene Corporation (Bristol-Myers Squibb Company), CSL Limited, Grifols SA, HiMedia Laboratories, Medxbio Pte Ltd, Merck KGaA, Octapharma AG, Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc. and Ventria Bioscience Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Product, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Albumedix Ltd, Biotest AG, Celgene Corporation (Bristol-Myers Squibb Company), CSL Limited, Grifols SA, HiMedia Laboratories, Medxbio Pte Ltd, Merck KGaA, Octapharma AG, Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc. and Ventria Bioscience Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Albumin Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Human Serum Albumin
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Bovine Serum Albumin
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Recombinant Albumin
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Application
    7.1    Therapeutics
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Drug Formulation and Vaccine
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Component of Media
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Others
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by End User
    8.1    Hospitals and Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Pharmaceutical and Biotechnology Companies
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Research Institutes
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Albumedix Ltd
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    Biotest AG
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Celgene Corporation (Bristol-Myers Squibb Company)
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 SWOT Analysis
        14.3.4    CSL Limited
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Grifols SA
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    HiMedia Laboratories
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    Medxbio Pte Ltd
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Merck KGaA
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Octapharma AG
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 SWOT Analysis
        14.3.10    Takeda Pharmaceutical Company Limited
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Thermo Fisher Scientific Inc.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Ventria Bioscience Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio

List of Figures

Figure 1: Global: Albumin Market: Major Drivers and Challenges
Figure 2: Global: Albumin Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Albumin Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Albumin Market: Breakup by Product (in %), 2021
Figure 5: Global: Albumin Market: Breakup by Application (in %), 2021
Figure 6: Global: Albumin Market: Breakup by End User (in %), 2021
Figure 7: Global: Albumin Market: Breakup by Region (in %), 2021
Figure 8: Global: Albumin (Human Serum Albumin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Albumin (Human Serum Albumin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Albumin (Bovine Serum Albumin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Albumin (Bovine Serum Albumin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Albumin (Recombinant Albumin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Albumin (Recombinant Albumin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Albumin (Therapeutics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Albumin (Therapeutics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Albumin (Drug Formulation and Vaccine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Albumin (Drug Formulation and Vaccine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Albumin (Component of Media) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Albumin (Component of Media) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Albumin (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Albumin (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Albumin (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Albumin (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Albumin (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Albumin (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Albumin (Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Albumin (Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Albumin Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Albumin Industry: SWOT Analysis
Figure 78: Global: Albumin Industry: Value Chain Analysis
Figure 79: Global: Albumin Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Albumin Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Albumin Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Albumin Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Albumin Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Albumin Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Albumin Market: Competitive Structure
Table 7: Global: Albumin Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global albumin market was valued at US$ 5.4 Billion in 2021.

We expect the global albumin market to exhibit a CAGR of 6.15% during 2022-2027.

The growing utilization of albumin as a blood volumizer to aid in treating rare diseases, burns, liver disorders, surgical complications, etc., is primarily driving the global albumin market.

The sudden outbreak of the COVID-19 pandemic has led to the rising application of albumin in producing vaccines against the coronavirus infection and to aid in the treatment of acute respiratory distress syndrome as well as transporting essential nutrients to the body.

Based on the product, the global albumin market can be segmented into human serum albumin, bovine serum albumin, and recombinant albumin. Currently, human serum albumin holds the majority of the total market share.

Based on the application, the global albumin market has been divided into therapeutics, drug formulation and vaccine, component of media, and others. Among these, therapeutics currently exhibit a clear dominance in the market.

Based on the end user, the global albumin market can be categorized into hospitals and clinics, pharmaceutical and biotechnology companies, and research institutes. Currently, hospitals and clinics account for the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global albumin market include Albumedix Ltd, Biotest AG, Celgene Corporation (Bristol-Myers Squibb Company), CSL Limited, Grifols SA, HiMedia Laboratories, Medxbio Pte Ltd, Merck KGaA, Octapharma AG, Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc., and Ventria Bioscience Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links